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High Dietary Acid Load Predicts ESRD among
Adults with CKD
Tanushree Banerjee,* Deidra C. Crews,†‡ Donald E. Wesson,§ Anca M. Tilea,| Rajiv Saran,|¶
Nilka Ríos-Burrows,** Desmond E. Williams,** and Neil R. Powe,*†† for the Centers for
Disease Control and Prevention Chronic Kidney Disease Surveillance Team
*Division of General Internal Medicine, Department of Medicine, University of California, San Francisco, California;
†
Division of Nephrology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore,
Maryland; ‡Welch Center for Prevention, Epidemiology and Clinical Research, Johns Hopkins Medical Institutions,
Baltimore, Maryland; §Department of Internal Medicine, Texas A&M College of Medicine and Scott and White
Healthcare, Temple, Texas; |Kidney Epidemiology and Cost Center and ¶Division of Nephrology, Department of
Medicine, University of Michigan, Ann Arbor, Michigan; **Division of Diabetes Translation, Centers of Disease and
Control and Prevention, Atlanta, Georgia; and ††Department of Medicine, San Francisco General Hospital, San
Francisco, California

ABSTRACT
Small clinical trials have shown that a reduction in dietary acid load (DAL) improves kidney injury and slows
kidney function decline; however, the relationship between DAL and risk of ESRD in a population-based
cohort with CKD remains unexamined. We examined the association between DAL, quantiﬁed by net acid
excretion (NAEes), and progression to ESRD in a nationally representative sample of adults in the United
States. Among 1486 adults with CKD age$20 years enrolled in the National Health and Nutrition Examination Survey III, DAL was determined by 24-h dietary recall questionnaire. The development of ESRD was
ascertained over a median 14.2 years of follow-up through linkage with the Medicare ESRD Registry. We
used the Fine–Gray competing risks method to estimate the association of high, medium, and low DAL
with ESRD after adjusting for demographics, nutritional factors, clinical factors, and kidney function/damage
markers and accounting for intervening mortality events. In total, 311 (20.9%) participants developed ESRD.
Higher levels of DAL were associated with increased risk of ESRD; relative hazards (95% conﬁdence interval)
were 3.04 (1.58 to 5.86) for the highest tertile and 1.81 (0.89 to 3.68) for the middle tertile compared with the
lowest tertile in the fully adjusted model. The risk of ESRD associated with DAL tertiles increased as eGFR
decreased (P trend=0.001). Among participants with albuminuria, high DAL was strongly associated with
ESRD risk (P trend=0.03). In conclusion, high DAL in persons with CKD is independently associated with
increased risk of ESRD in a nationally representative population.
J Am Soc Nephrol 26: 1693–1700, 2015. doi: 10.1681/ASN.2014040332

CKD is a major public health problem affecting
.10% of the United States population.1 CKD is
associated with substantial morbidity, cardiovascular disease, ESRD, and death. High rates of morbidity and mortality are evident not only in patients
with ESRD but also, among those with only mildly
decreased kidney function.1,2 Developing safe and
effective kidney-protective interventions to slow or
stop the progression of established CKD is essential
to reduce the risk of kidney failure associated with
the increasing prevalence of CKD.
J Am Soc Nephrol 26: 1693–1700, 2015

Previous literature has shown that diet can
markedly affect the acid–base status,3–5 and it signiﬁcantly inﬂuences the risk of CKD progression.6,7
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Metabolic acidosis, a complication in CKD patients due to
decreased renal acid excretion, is a modiﬁable risk factor for
CKD progression.7,8 Acid-inducing diets are believed to affect
the kidney by tubular toxicity of elevated ammonium concentrations and activation of the renin-angiotensin system or the
alternative complement pathway, but the exact mechanism is
unknown.9,10 With increased dietary acid load (DAL), production of ammonia is increased in the proximal tubule, and H+
excretion is increased distally to augment overall acid excretion
and contribute to disease progression.8,11 A cross-sectional study
shows the association between increased DAL and prevalent
CKD.12 Previous small translational studies have shown that
alkali supplements or diets high in fruits and vegetables can
lower acid excretion and slow disease progression.7,8
To our knowledge, there are no previously reported data on
the relation of DAL and CKD progression in a nationally
representative sample. In light of these observations, we sought
to examine the association between high DAL, quantiﬁed by
dietary net acid excretion (NAEes), and progression to ESRD in
the 1988–1994 National Health and Nutrition Examination
Survey (NHANES III). We also examined whether the association of DAL with ESRD would be stronger in those with
evidence of more advanced CKD (eGFR,45 ml/min per
1.73 m2) compared with those with mild/moderate CKD
(eGFR$45 ml/min per 1.73 m2) and in adults with albuminuria$30 mg/g than in those with albuminuria,30 mg/g.

RESULTS

In total, 1486 NHANES III participants with CKD who were
$20 years of age, did not have missing data on dietary intake,
had an eGFR$15 and ,60 ml/min/1.73 m2, and were not
pregnant were included. There were no signiﬁcant differences
in the sociodemographic and clinical characteristics of the
participants who we included in our study and those we excluded, except age (those included were a mean of 73.1 years of
age compared with those excluded, who were 80.4 years of age;
P value,0.001).
The median value of estimated DAL, calculated using the
formula by Remer and Manz,3 was 47.24 mEq/d (25th–75th percentiles=34.36–59.38 mEq/d). High DAL was associated with
younger age, men, and non-Hispanic black race (Table 1). Participants with total caloric intake.2000 kcal/d and body surface
area (BSA)$1.73 m2 were also more likely to have greater DAL.
Associations of DAL with ESRD

During a median of 14.2 years (25th–75th percentiles=2.5–
16.2 years), 311 (20.9%) NHANES III participants developed
ESRD. The incidence rate of ESRD per 1000 person-years corresponding to the lowest tertile of DAL was 10.8 (95% conﬁdence interval [95% CI], 3.2 to 26.2), the middle tertile was
23.1 (95% CI, 3.2 to 26.2), and the highest tertile was 52.1
(95% CI, 37.4 to 88.7). In this population, the unadjusted
hazard of ESRD was greater with higher DAL (Figure 1).
1694
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Participants in the highest DAL tertile showed an increased
relative hazard (RH) of ESRD compared with the referent
group (lowest tertile) in age-, sex-, and race-adjusted analyses
(RH, 4.13; 95% CI, 2.09 to 7.81) (Table 2). Multivariable adjustment for nutritional factors of BSA, total caloric intake per
day, serum bicarbonate, and protein intake attenuated the risk
of ESRD to an RH of 3.45 (95% CI, 1.83 to 6.52). The risk was
further attenuated after additional adjustment for clinical risk
factors of diabetes and hypertension (RH, 2.73; 95% CI, 1.44
to 5.18). However, on adjustment for baseline eGFR and albuminuria, the RH increased to 3.04 (95% CI, 1.58 to 5.86)
compared with the referent group.
Given the nonlinear association with DAL, we ran our
multivariable competing risk model for estimating the risk of
ESRD with linear and quadratic terms for DAL. The multivariableadjusted RH per mEq per day increase in DAL was 1.39 (95% CI,
1.19 to 1.63) (Figure 2).
Associations of DAL with ESRD by eGFR and
Albuminuria

The association between higher DAL and ESRD was more
pronounced in participants with more advanced CKD than
mild/moderate CKD (P interaction for DAL and eGFR=0.05)
(Table 3). The risk of ESRD was associated with the tertiles of
DAL in a graded fashion among both participants with advanced CKD (P trend=0.001) and participants with moderate
CKD (P trend=0.04). High DAL was only statistically signiﬁcantly associated with risk of ESRD among participants with
albuminuria (P interaction for DAL and albuminuria,0.001)
(Table 3). Among participants with albuminuria, high DAL
was associated with risk of ESRD in a graded fashion
(P trend=0.03 in multivariable-adjusted models).
Additionally, in competing risk analyses, results were still
signiﬁcant if death was included as the end point in lieu of being
treated as a competing risk, but the strength of the association
was attenuated. The RH for the association of the highest tertile
of DALwas 1.41 (95% CI, 1.01 to 1.97) compared with the lowest
tertile. However, we did not observe a statistically signiﬁcant trend toward an increased risk of mortality with DAL
(P trend=0.07).
Sensitivity Analyses

Early Events of ESRD in NHANES III
When we examined early events of ESRD (time to follow-up,6
years), the results were similar to our primary analysis. There
were 102 (18.3%) ESRD events. The multivariable-adjusted
hazard ratios for ESRD for the middle and highest tertiles of
DAL compared with the lowest tertile were 1.66 (95% CI, 0.56
to 3.34) and 4.61 (95% CI, 1.27 to 7.59), respectively.
ESRD in Continuous NHANES (1999–2004)
When 1386 participants with CKD in NHANES 1999–2004
were examined for progression to ESRD, the RH for incident
ESRD in the multivariable model comparing the highest tertile
of DAL with the referent group was 2.80 (95% CI, 1.26 to
J Am Soc Nephrol 26: 1693–1700, 2015
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Table 1. Baseline characteristics of 1486 NHANES III participants with CKD (eGFR=15–59 ml/min per 1.73 m2) according
to DAL
DAL (mEq/d), %
Parameter
Sociodemographic factors
Age (yr)
20–50
50–70
.70
Men (%)
Race
Asian
Hispanic
African American
White
PIR
$2
,2
Education
Less than high school
Some college
More than college
Nutritional factors
BSA ($1.73 m2)
Total calories (.2000 kcal/d)
Serum bicarbonate (,22 mmol/L)
Clinical factors
Diabetes (yes)
Hypertension (yes)
Kidney function/damage markers
eGFR (ml/min per 1.73 m2)
15–40
40–60
Albuminuria (.30 mg/g)

n

Low (Minimum to
39.24; n=490)

Middle (39.24–55.43;
n=505)

High (55.23 to
Maximum; n=491)

84
619
783
684

15.5
23.6
42.4
32.4

52.4
32.8
32.9
46.7

32.1
43.6
24.6
58.9

40
185
368
893

3.9
10.8
16.9
68.4

1.6
12.7
25.7
60.0

2.7
13.9
31.6
51.8

581
733

47.6
52.4

43.6
56.4

41.6
58.4

818
506
153

51.9
38.0
10.1

52.4
33.1
14.5

61.9
31.7
6.4

998
322
91

41.9
13.8
5.2

75.2
20.4
2.6

84.1
30.8
11.2

,0.001
0.003
0.34

440
1256

23.8
85.9

28.1
84.9

36.9
82.7

0.12
0.59

393
1093
666

24.4
75.6
40.3

24.8
75.2
45.9

30.2
69.8
48.2

P Value
,0.001

0.11
0.48

0.57

0.33

0.78

0.48

PIR is the ratio of family income to poverty threshold. Hypertension was deﬁned by self-report, average BP.140/90 mmHg, or use of medications.

6.25). The RH for the association of the middle tertile of DAL
was 1.61 (95% CI, 0.72 to 4.47) compared with the lowest
tertile. We observed a trend toward an increased risk of
ESRD in participants with greater DAL (P trend=0.01).
CKD Epidemiology Collaboration Equation
We noted 270 (20.3%) ESRD events in 1332 NHANES III
participants for whom baseline CKD was deﬁned using the
CKD Epidemiology Collaboration13 (CKD-EPI) equation.
The risk of ESRD when adjusted for potential confounders
was qualitatively similar compared with that estimated using
the Modiﬁcation of Diet in Renal Disease (MDRD) Study
equation (Table 2).

DISCUSSION

In this study, our main ﬁndings suggest (1) an association
between high levels of DAL as estimated by high NAEes and
J Am Soc Nephrol 26: 1693–1700, 2015

increased risk of progression to ESRD, (2) a strong association
of high DAL and CKD progression in both advanced and moderate CKD, and (3) an association of risk of ESRD with high
levels of DAL among individuals with albuminuria$30 mg/g
compared with those with normal albuminuria,30 mg/g.
Even for a shorter duration of follow-up (,6 years), a much
greater risk of ESRD was seen with high DAL. To the best of
our knowledge, this is the ﬁrst longitudinal study on the association of DAL and progression to ESRD in a nationally
representative cohort. To date, small studies in animal models
and patients have examined the association between DAL and
CKD progression7,8 and conﬁrm that increased acid excretion
may promote kidney injury. The size and the completeness of
follow-up of our study along with the detailed collection of
nutritional parameters and standardized laboratory testing in
NHANES speak to the point that the results should be considered in the balance of large evidence on dietary acid in CKD
progression. In our study, we found that high DAL is associated with an increased RH of ESRD in not only participants
Dietary Acid and ESRD
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Figure 1. A greater risk of ESRD was associated with a higher dietary acid load (DAL). Crude cumulative probability of ESRD for
participants with varying levels of DAL.

with advanced CKD stages but also, participants with moderate CKD. Our results corroborate ﬁndings from prior studies
that have shown progressive GFR decline by acid-inducing
diets in subjects with hypertensive nephropathy and relatively
preserved CKD (eGFR=60–90 ml/min per 1.73 m2).9
Food intake can affect the body’s acid–base balance through
supply of acid precursors (i.e., noncarbonic acids, such as sulfuric acid) or base precursors (i.e., alkali salts from organic
acids [OAs], such as citrate and bicarbonate). In general, meat,
ﬁsh, cheese, grain products, and rice are relatively strong net
acidifying foods, which are also high in phosphate, whereas
fruit (apples, peaches, and raisins), legumes, vegetables (spinach
and cauliﬂower), and potatoes are relatively strong net alkalinizing foods, and foods low in acid, such as potassium, are
potentially renal-protective. Our contemporary Western diets
are shifting from relatively alkalinizing toward more acidifying.

The consequence of high DAL is a state of metabolic acidosis,
which is a common complication of advanced CKD.14 Our ﬁndings suggest that high DAL plays a role in the progression of
kidney disease. They reinforce the ﬁndings of earlier studies
that have shown beneﬁcial effects of alkali supplementation in
slowing the progression of kidney disease7,8 and studies documenting the association of metabolic acidosis with CKD progression.15,16
We noted an association of DAL and progression to ESRD
for participants with albuminuria. Our ﬁndings are in accordance with previous studies that have shown high consumption of meat food groups (i.e., each serving per day greater
intake of the sum of red meat, processed meat, poultry, and
ﬁsh) to be positively associated with albuminuria.17,18 By
contrast, a dietary pattern characterized by high consumption
of fruits and vegetables (i.e., each serving per day greater intake

Table 2. Adjusted RH for progression to ESRD for low, middle, and high tertiles of estimated DAL in NHANES III participants
Model Adjustment

Low

Demographic factors
+Nutritional factors
+Clinical factors
+Kidney function/
damage status

1.00 (ref)
1.00 (ref)
1.00 (ref)
1.00 (ref)

MDRD Equation RH (95% CI)

CKD-EPI Equation RH (95% CI)

n

Middle

High

P Trend

n

Middle

High

P Trend

1486
1251
1251
1195

2.16 (1.06 to 4.42)
2.09 (1.01 to 4.32)
1.59 (0.78 to 3.25)
1.81 (0.89 to 3.68)

4.13 (2.09 to 7.81)
3.45 (1.83 to 6.52)
2.73 (1.44 to 5.18)
3.04 (1.58 to 5.86)

0.03
0.04
0.06
0.05

1332
1130
1130
1081

3.10 (1.79 to 6.95)
2.81 (1.23 to 6.36)
1.53 (1.02 to 2.29)
1.62 (1.06 to 2.48)

6.10 (3.10 to 9.31)
4.45 (2.23 to 8.89)
2.75 (1.51 to 5.01)
3.14 (1.70 to 5.82)

0.008
0.03
0.04
0.01

Demographic factors are age, sex, and race. Nutritional factors are BSA, total caloric intake per day, serum bicarbonate, and protein intake. Clinical factors are
diabetes and hypertension. Kidney function/damage status includes eGFR and albuminuria. ref, Reference.
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participants’ urine because of a lack of
24-hour urine collections in NHANES.
Fourth, our results for the fully adjusted
model showed that it was the calculated
DAL rather than the protein intake that
was associated with risk of ESRD. Future
research should attempt to better clarify
this distinction. Fifth, our results may
have been inﬂuenced by unmeasured confounders, including direct measures of acidosis and time-varying variables such as
caloric intake.
Our study represents one of the largest
cohorts with a long duration of follow-up,
establishing that high DAL is associated
with poor outcomes in CKD. Our ﬁndings
are consistent with those of Scialla et al.,14
who found that higher net endogenous
acid production is associated with a faster
rate of CKD progression in African Americans with hypertensive nephropathy. Although prior studies have suggested that
Figure 2. An increase of 1-mEq/d in estimated dietary acid load was associated with the risk for CKD progression may be mitia signiﬁcant relative hazard of ESRD in the multivariable-adjusted model.
gated by a reduction in the DAL, this area
remains controversial, because some studies found that the combination of chronic metabolic acidosis
of the sum of fruits, fruit juice, vegetables, nuts, and legumes)
and phosphate loading in animal models may protect against
was inversely associated with albuminuria. Because albuminthe progression of renal failure.19,20
uria is a major risk factor for ESRD progression, our data
suggest that higher DAL may lead to kidney injury, which
In summary, we have observed that DAL in the upper range
may portend progression to ESRD.
is associated with an increased risk of ESRD, and this ﬁnding
There are certain limitations in our study. First, in NHANES
may have important public health implications. Clinical and
III, we did not have laboratory follow-up data. Thus, there is a
public health strategies focusing on improving diet quality on
possibility of misclassiﬁcation of CKD risk factors, such as
population and individual patient levels could potentially
diabetes and hypertension, that are deﬁned from measureimprove CKD outcomes.
ments at a single time point. Second, we analyzed participants
who had complete data on their dietary recall interview, thus
introducing the potential for selection bias. However, there CONCISE METHODS
were no signiﬁcant differences in the sociodemographic and
clinical characteristics in the participants who we included in
Study Population and Baseline Data
our study and those who we excluded, except age. Third, we
NHANES III was a national probability sample of United States
estimate DAL from 24-hour dietary recall data using previously noninstitutionalized civilians conducted between 1988 and 1994 by
validated equations rather than directly measuring NAE in
the National Center for Health Statistics (NCHS). For this analysis, we

Table 3. Adjusted RH for ESRD associated with tertiles of estimated DAL stratiﬁed by eGFR and albuminuria
Model Adjustment

Low

MDRD Equation (95% CI)
n

Middle

CKD-EPI Equation (95% CI)

High

P Trend

n

2.63 (1.35 to 4.13)
4.25 (1.81 to 9.95)

0.04
0.001

671 1.44 (0.70 to 2.17) 2.26 (1.14 to 3.48)
536 2.12 (1.04 to 4.33) 3.83 (1.68 to 8.71)

0.001
0.001

1.19 (0.54 to 2.64)
2.52 (1.10 to 5.76)

0.21
0.03

654 0.76 (0.28 to 2.10) 1.04 (0.44 to 2.52)
553 3.24 (1.19 to 8.86) 4.39 (1.89 to 10.22)

0.06
0.02

Middle

High

P Trend

2

eGFR (ml/min per 1.73 m )
$45
1.00 (ref) 854 1.55 (0.35 to 2.88)
,45
1.00 (ref) 485 2.33 (1.06 to 5.10)
Albuminuria (mg/g)
,30
1.00 (ref) 722 0.77 (0.44 to 1.39)
$30
1.00 (ref) 617 2.42 (1.14 to 5.18)

Adjusted for demographic factors (age, sex, and race), nutritional factors (BSA, total caloric intake per day, serum bicarbonate, and protein intake), clinical factors
(diabetes and hypertension), and kidney function/damage status (eGFR and albuminuria). ref, Reference.
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included participants$20 years of age who did not have missing data
on dietary intake, had an eGFR$15 and ,60 ml/min per 1.73 m2,
and were not pregnant (n=1468).

Sociodemographic and Clinical Measurements
Medical history and demographic data were collected through a
standardized survey conducted at the participant’s home followed by a
medical examination and laboratory testing that occurred in the mobile examination center.21
Sociodemographic factors were assessed during the interview.
Racial/ethnic categories were self-reported by participants and
assigned as non-Hispanic white, non-Hispanic black, and Mexican
American. Self-reported information on socioeconomic position
(education and income) was obtained during the interview portions of
the survey. Income was assessed using the poverty income ratio (PIR),
which is a ratio of household income to household poverty level.21
Diabetes was deﬁned by self-report of the condition or measured
hemoglobin A1c$6.5%.22 Hypertension was deﬁned by self-report of
being told by a health care provider of having the condition, a measured average systolic BP$140 mmHg or average diastolic BP$90
mmHg, or reported use of antihypertensive medications.23

Measurement and Classiﬁcation of Serum Bicarbonate,
Albuminuria, and Kidney Function
Serum bicarbonate was measured using the Hitachi 737 multichannel
analyzer (Boehringer Mannheim Diagnostics, Indianapolis, IN).
Serum bicarbonate was measured using the phosphoenolpyruvate
method. Serum creatinine measurements obtained using a kinetic rate
Jaffé method in NHANES III were recalibrated to standardized creatinine measurements obtained at the Cleveland Clinic Research Laboratory (Cleveland, OH) as standard creatinine=0.184+0.9603NHANES
III-measured serum creatinine.24 Random spot urine samples were obtained and frozen. Urine albumin was measured using a solid-phase
ﬂuorescence immunoassay, and urine creatinine was measured using
the modiﬁed Jaffé kinetic method in the same laboratory. eGFR was
calculated according to the isotope dilution mass spectrometrytraceable four-variable MDRD Study equation for calibrated creatinine.25
CKD was deﬁned as eGFR,60 ml/min per 173 m2. Albuminuria, which
was calculated as the urinary albumin-to-creatinine ratio (UACR), was
expressed as milligrams of albumin per gram of creatinine using American Diabetes Association categories: normal (,30 mg/g creatinine) and
albuminuria ($30 mg/g creatinine).26

Dietary Assessment and DAL
The dietary intake data collected in NHANES III were used to estimate
the types and amounts of foods and beverages consumed during the
24-hour period before the interview (midnight to midnight) and
estimate intake of energy, nutrients, and other food components from
those foods and beverages. The NHANES III second examination ﬁles
for dietary recall were a substudy of NHANES III. We, therefore,
carried out our analysis on the basis of the data of the dietary interview
component from the primary examination. The nonbicarbonate
anions (protein and phosphorus) intake and the mineral cations
(potassium, magnesium, and calcium) intake of foods consumed by
participants were derived from the dietary intake data. Potential renal
1698
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acid load (PRAL) of foods consumed by the participants was calculated
using the calculation model by Remer and Manz3 [PRAL (mEq/d)
=0.493protein (g)+0.0373phosphorus (mg)]20.0213potassium
(mg)20.0263magnesium (mg)20.01253calcium (mg)]. DAL was estimated as NAEes (mEq/d)=PRAL+OAs, where OAwas calculated as OA
(mEq/d)=(BSA (m2)341 (mEq/d per 1.73 m2)/1.73 m2).3 This calculation method, primarily on the basis of PRAL, allows for an appropriate
prediction of the effects of diet on the acidity of urine. DAL provides an
estimate of the production of the endogenous acid that exceeds the level
of alkali produced for given amounts of food ingested daily. The method
of calculation of NAEes was experimentally validated in healthy adults
and showed that acid loads and renal NAE can be reliably estimated
from diet composition.3,27

Follow-Up Data
In our study, the primary outcome studied was the development of
ESRD. In NHANES III, ESRD incidence was deﬁned as initiating
chronic dialysis. ESRD events and mortality follow-up data from the
time of the survey (1988–1994) through December 31, 2006, were
determined from the Medicare ESRD Registry and National Death
Index, which were linked to NHANES III.28 ESRD data are available
for those NCHS respondents who agreed to provide personal identiﬁcation data to NCHS and for whom NCHS was able to match with
United States Renal Data System administrative records.

NHANES 1999–2004
Because the continuous NHANES was a more contemporary cohort,
we repeated our analysis using the NHANES 1999–2004 data. DAL
was assessed using the dietary questionnaire. We used the same set of
sociodemographic variables and the medical history data as in
NHANES III collected through a standardized survey conducted at
the participant’s home followed by a medical examination and laboratory testing that occurred in the mobile examination center. The
clinical measurements (diabetes, hypertension, and CKD) were deﬁned as in NHANES III. The continuous NHANES was also linked to
the Medicare ESRD Registry and National Death Index, where again,
ESRD incidence was deﬁned as in NHANES III.

Statistical Analyses
Baseline characteristics of study participants across DAL tertiles were
compared using chi-squared tests for categorical variables and oneway ANOVA for continuous variables. Kruskal–Wallis test was used
for the continuous variables if the normality assumption of the residuals was not met. Baseline DAL was considered both in tertiles
(lowest: minimum to ,39.24 mEq/d; middle: 39.24–55.43 mEq/d;
highest: 55.4 to maximum mEq/d) and as a continuous variable
(per 1 mEq/d higher DAL level). We investigated the association of the
tertiles of DAL with the development of ESRD in subjects using the
competing risks method by Fine and Gray29 to account for potential
bias caused by the competing risk of death before ESRD. We investigated nonlinear associations between DAL and risk of ESRD by
incorporating splines with ﬁve knots in our analysis. Because of nonlinearity (P value,0.001), we presented our results as tertiles of DAL
associated with risk of ESRD. We even estimated the risk of ESRD
with linear and quadratic terms for DAL in our multivariable
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competing risk model. Covariates hypothesized to contribute to CKD
progression were included in the adjusted models if they were associated with progression of CKD in univariate analyses (P,0.20). There
was an indication of colinearity of moderate strength between age and
PIR (Variance Inﬂation Factor=3.26, tolerance=0.31, condition index=14.43). Therefore, we analyzed our data by excluding the socioeconomic position factors (PIR and education level). Models were
adjusted for demographic factors (age, sex, and race/ethnicity), nutritional factors (BSA, total caloric intake per day, serum bicarbonate,
and protein intake), clinical factors (diabetes and hypertension), and
kidney function/damage markers (eGFR and albuminuria).
Stratiﬁed models were generated by categories of baseline eGFR
(eGFR$45 versus ,45 ml/min per 1.73 m 2 ) and albuminuria
(UACR$30 mg/g creatinine versus UACR,30 mg/g creatinine).
Models were adjusted for the covariates selected on the basis of
P level (P,0.20) in univariate Cox proportional hazards models.
The cutpoint for eGFR in this study is clinically relevant and consistent with prior literature and current practice guidelines.30 Potential
effect modiﬁcation between DAL and baseline eGFR and albuminuria
was examined using interaction terms in the adjusted models. P trend
across DAL tertiles was calculated by modeling them as continuous
variables.
We ran additional analyses for death as the primary end point and
ESRD as the competing risk to see if acidogenic diet was also a risk of
mortality.
Three sets of sensitivity analyses were performed to test the
robustness of our ﬁndings. First, we examined the association of DAL
with early events (time to follow-up,6 years) of ESRD to determine
if high DAL was associated with early events. Second, an analysis was
conducted to examine the association of DAL with ESRD in the
continuous NHANES (1999–2004) cohort, which is a more contemporary cohort than NHANES III. Third, we used the CKD-EPI equation13 to estimate GFR in our deﬁnition of CKD and then examined
the association of DAL with ESRD. Analyses included the survey
sample weights to account for the complex sample design of the
survey, and we followed the analytical guidelines for NHANES III
data as proposed by the Centers for Disease Prevention and Control.31 Fay’s balanced repeated replication procedure, an approach
for estimation of SEMs for multistage samples that consist of many
sampling units, was used for variance estimates. Results were considered signiﬁcant if P,0.05. All analyses were performed using SAS
9.2 (SAS Institute, Inc., Cary, NC).
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